
|Videos|July 22, 2021
Vyluma pipeline focuses on refractive error
Advertisement
Vyluma, which recently spun off from Nevakar, has a robust pipeline for potential therapies addressing refractive error. Navneet Puri, PhD, the company’s founder, chairman, and CEO, offers additional insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5






















